Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec 16:1:12.
doi: 10.3389/fcvm.2014.00012. eCollection 2014.

High-Sensitivity C-Reactive Protein is Related to Central Obesity and the Number of Metabolic Syndrome Components in Jamaican Young Adults

Nadia R Bennett  1 , Trevor S Ferguson  1 , Franklyn I Bennett  2 , Marshall K Tulloch-Reid  1 , Novie O M Younger-Coleman  1 , Maria D Jackson  3 , Maureen E Samms-Vaughan  4 , Rainford J Wilks  1
Affiliations

High-Sensitivity C-Reactive Protein is Related to Central Obesity and the Number of Metabolic Syndrome Components in Jamaican Young Adults

Nadia R Bennett et al. Front Cardiovasc Med. .

Abstract

Background: High-sensitivity C-reactive protein (hsCRP) has been shown to predict cardiovascular disease (CVD) endpoints and is associated with CVD risk factors and the metabolic syndrome. This study evaluated the association between hsCRP and CVD risk factors among Afro-Caribbean young adults in Jamaica.

Methods: We conducted a cross-sectional analysis of data from the Jamaica 1986 Birth Cohort Study. Data were collected between 2005 and 2007 when participants were 18-20 years old. All participants completed an interviewer administered questionnaire and had anthropometric and blood pressure (BP) measurements performed. Fasting blood samples were collected for measurement of glucose, lipids, and hsCRP. Logistic regression models were used to identify factors independently associated with high hsCRP.

Results: Analyses included 342 men and 404 women with mean age 18.8 ± 0.6 years. Approximately 15% of the participants had high risk hsCRP (>3 mg/L), with a higher prevalence among women (20 vs. 9%; p < 0.001). The prevalence of elevated hsCRP increased with body mass index category, high waist circumference (WC), high triglycerides, low high density lipoprotein, and lower parental education among women, but only for high WC and lower parental education among men. In logistic regression models controlling for sex and parental education, high WC was associated with significantly higher odds of high hsCRP (OR 7.8, 95% CI 4.8-12.9, p < 0.001). In a similar model, high hsCRP was also associated with the number of metabolic syndrome components. Compared to participants with no metabolic syndrome component, having one metabolic syndrome component was associated with a twofold higher odds of high hsCRP (OR 2.2, 95% CI 1.3-3.8, p = 0.005), while having three components was associated with a 14-fold higher odds of high hsCRP (OR 13.5, 95% CI 2.4-76.0, p < 0.001).

Conclusion: High hsCRP is common among Jamaican young adults and is strongly associated with central obesity and the number of metabolic syndrome components.

Keywords: Black; Caribbean; Jamaica; cardiovascular disease; high-sensitivity C-reactive protein; metabolic syndrome; young adults.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Proportion (%) of participants with high hsCRP based on number of metabolic syndrome components for male and female participants. The proportion of participants with high hsCRP increased with the number of the metabolic syndrome components for males (p = 0.025), and for females (p < 0.001). P-values were derived from chi-squared tests. Tests for trend were also significant: p = 0.011 for males; p < 0.001 for females. hsCRP, high sensitivity C-reactive protein.
See this image and copyright information in PMC

References

    1. Young I, Rifai N. High-sensitivity C-reactive protein and cardiovascular disease. Clin Chem (2009) 55(2):201–2.10.1373/clinchem.2008.120527 - DOI - PubMed
    1. Musunuru K, Kral BG, Blumenthal RS, Fuster V, Campbell CY, Gluckman TJ, et al. The use of high-sensitivity assays for C-reactive protein in clinical practice. Nat Clin Pract Cardiovasc Med (2008) 5(10):621–35.10.1038/ncpcardio1322 - DOI - PMC - PubMed
    1. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med (2000) 342(12):836–43.10.1056/NEJM200003233421202 - DOI - PubMed
    1. Mora S, Musunuru K, Blumenthal RS. The clinical utility of high-sensitivity C-reactive protein in cardiovascular disease and the potential implication of JUPITER on current practice guidelines. Clin Chem (2009) 55(2):219–28.10.1373/clinchem.2008.109728 - DOI - PubMed
    1. Yousuf O, Mohanty BD, Martin SS, Joshi PH, Blaha MJ, Nasir K, et al. High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link? J Am Coll Cardiol (2013) 62(5):397–408.10.1016/j.jacc.2013.05.016 - DOI - PubMed